Efficacy and Safety of Sodium-Glucose Cotransporter 2 Inhibitors in Type 2 Diabetes Management
Summary
Sodium–glucose cotransporter 2 (SGLT2) inhibitors represent a transformative class of oral antihyperglycaemic agents that lower renal glucose reabsorption and promote glycosuria. Beyond their capacity to reduce HbA1c, these agents confer consistent reductions in body weight and systolic blood pressure, and they have demonstrated renoprotective and cardioprotective effects across diverse patient populations. Large outcome trials have shown that SGLT2 inhibitors diminish the risk of hospitalisation for heart failure and slow progression of chronic kidney disease, independent of baseline glycaemic control. Safety profiles are characterised by an increased incidence of genital mycotic and urinary tract infections, modest natriuresis‐related volume depletion, and rare episodes of diabetic ketoacidosis in predisposed individuals. Across global real-world and clinical settings, the balance of efficacy and tolerability has supported guideline recommendations favouring SGLT2 inhibitors for patients with type 2 diabetes who have established cardiovascular or renal disease or who remain suboptimally controlled on first-line therapy. Their insulin-independent mechanism also permits combination with multiple antidiabetic regimens, enhancing individualised management strategies.
Research from Nature Portfolio
No recent Nature Portfolio content available.
Efficacy and Safety of Sodium-Glucose Cotransporter 2 Inhibitors in Type 2 Diabetes Management publication trend
The graph below shows the total number of articles in efficacy and safety of sodium-glucose cotransporter 2 inhibitors in type 2 diabetes management across all publications each year (not limited to Nature Index journals).
Technical terms
Sodium–glucose cotransporter 2 (SGLT2) inhibitors: Drugs that block glucose reabsorption in the proximal renal tubule, promoting urinary glucose excretion.
Glycated haemoglobin (HbA1c): A marker of average blood glucose over 8–12 weeks, expressed as a percentage of haemoglobin bound by glucose.
Osmotic diuresis: Enhanced urine production resulting from elevated solute concentration in the renal filtrate, leading to fluid loss.
Diabetic ketoacidosis (DKA): A life-threatening complication characterised by hyperglycaemia, ketosis and metabolic acidosis.
Randomised controlled trial (RCT): A study design in which participants are allocated at random to interventions, minimising bias in efficacy and safety assessments.
References
- Safety and effectiveness of SGLT2 inhibitors in a UK population with type 2 diabetes and aged over 70 years: an instrumental variable approach. Diabetologia (2024).
- A multicentre, prospective, non-interventional study evaluating the safety of dapagliflozin in patients with type 2 diabetes in routine clinical practice in China (DONATE). BMC Medicine (2023).
- Comparative safety of different sodium-glucose transporter 2 inhibitors in patients with type 2 diabetes: a systematic review and network meta-analysis of randomized controlled trials. Frontiers in Endocrinology (2023).
Turn complex research questions into confident strategic decisions
When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.
Benchmark your performance against global peers using robust, methodologically sound analysis.
Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.
Gain tailored, decision-ready recommendations aligned to your strategic priorities.
Talk to us to learn more about our data dashboards and bespoke strategy reports.
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.
Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:
Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.
Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.
Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.
Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.